A Case Report of a Patient with a Rare and Aggressive Plasma Cell Leukemia

Abstract

Plasma cell leukemia (PCL) is the most aggressive form of the plasma cell dyscrasias. This rare disease remains a challenge in regard to diagnosis and treatment due to its rarity and aggressive nature. PCL is a rare plasma cell malignancy with poor prognosis. There is still limited literature and numerous trials on this disease treatment. Novel agents and autologous stem cell transplant can be given to prolong survival and increase life quality. Reports on PCL is very important for references regarding future treatments.